Delivery Order SPE2DR25D3505-SPE2DR26F96E6
Award Date 12/30/25
Potential Completion Date 12/31/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of GRALISE ER 300 mg tablets (90-count packages) with a contract value of $1,479.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the company's...
- This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of the medication GRALISE ER 600 MG TABLET 90S, with a Ceiling Value of $4,766.95 and a completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and designated as SPE2DX. This IDC provides a...
- This is a $8,879.52 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, particularly the military healthcare...
- This federal contract award is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,283.20, is for the provision of GRALISE ER 600 MG TABLET 90S. The award has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,799.72 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication product. The contract, which has a period of performance ending on July 30, 2024, does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous contracts by various...
- The Defense Logistics Agency Troop Support Medical awarded a $7,189.59 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561696287 GRALISE ER 600 MG tablets. Under the contract, Amerisourcebergen will deliver 90 tablets of the specified medication to a facility located in Conshohocken, Pennsylvania by August 4, 2023. No additional details were provided regarding the original solicitation or whether this award was issued against an existing government-wide acquisition...
- The Defense Logistics Agency awarded a $1,389.06 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Horizant ER 600 mg tablets (30-count). This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract valued at $11,562.36 from the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This contract, designated as a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, represents a child award under a larger indefinite delivery contract vehicle. The contract carries no set-aside designation, indicating it...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $11,562.36 by the Defense Logistics Agency's Medical Supply Chain on December 6, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the company's corporate office in...